Ticker brief
RXRX RECURSION PHARMACEUTICALS-A
Consumer, Non-cyclical · Biotechnology
last close
$3.34
1 day
-2.9%
14 days
+5.7%
mkt cap
$2.0B
signals 14d
22
authors 14d
14
crowd 14d
+1.6σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 79% cheap · 7 pctile own 1y | IV/HV 1.28× (as of 2026-07-24) |
| Skew — 25Δ RR 30d | +0.132 35 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +1.41 elevated | 5-session Δ -0.73 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-05-29 (z=3.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-26 · now +0.25 (−1 bearish … +1 bullish)
Who spoke14
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @iTradeCharts | C | -2.58 | 3 | +0.47 |
| @jrouldz | B | -1.60 | 2 | +0.25 |
| @CaesarCapitalz | C | -0.81 | 2 | +0.42 |
| @Reformed_Trader | C | -3.02 | 2 | +0.55 |
| @beach_trades | C | -0.04 | 2 | +0.35 |
| @FloridaHokie20 | C | -1.51 | 2 | +0.75 |
| @EchoAnalysis | C | -1.44 | 2 | +0.75 |
| @BullrunIO | B | -0.13 | 1 | +0.00 |
| @InvestmentGuru_ | C | +0.12 | 1 | +0.10 |
| @cfaryanoconnell | C | -1.48 | 1 | +0.85 |
| @StockChaser_ | C | -2.36 | 1 | +0.35 |
| @SandmanMarkets | C | -2.91 | 1 | +0.65 |
| @OpenOutcrier | C | · | 1 | +0.25 |
| @schaeffers | C | +3.18 | 1 | +0.25 |
Recent signals22of 22 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @schaeffers | +0.25 | Reports call-heavy options flow across the listed names. | -4.3% | tweet ↗ |
| 2026-08-26 | @OpenOutcrier | +0.25 | Recaps unusual call activity; capped at the first six tickers. | -4.3% | tweet ↗ |
| 2026-08-26 | @iTradeCharts | +0.25 | Author discloses positions in critical-metals, nuclear and RXRX themes with stops moved to cost. | -4.3% | tweet ↗ |
| 2026-08-25 | @EchoAnalysis | +0.75 | Will buy RXRX if the 50WMA flips to support. — Sets a conditional long entry after a 50WMA support flip and cites 373% upside to the wedge top. | -6.2% | tweet ↗ |
| 2026-08-25 | @FloridaHokie20 | +0.80 | Says all four stocks could rise 200% and remain undervalued. | -6.2% | tweet ↗ |
| 2026-08-25 | @SandmanMarkets | +0.65 | Expresses broad bullishness on biotech and names four especially attractive stocks. | -6.2% | tweet ↗ |
| 2026-08-23 | @StockChaser_ | +0.35 | Identifies a tight descending wedge and says a breakout could produce a significant RXRX move. | -4.6% | tweet ↗ |
| 2026-08-22 | @EchoAnalysis | +0.75 | Buy RXRX if the 50WMA is reclaimed and flipped to support. — Defines a conditional breakout buy after reclaiming the 50WMA, with 379% upside to the wedge top. | -4.6% | tweet ↗ |
| 2026-08-21 | @cfaryanoconnell | +0.85 | Claims five biotech stocks could rise tenfold within five years. | -4.6% | tweet ↗ |
| 2026-08-21 | @iTradeCharts | +0.60 | Expects an RXRX breakout as MRNA renews attention on related biotechnology names. | -4.6% | tweet ↗ |
| 2026-08-20 | @beach_trades | +0.25 | Briefly agrees that RXRX shares the positive attribute under discussion | +0.0% | tweet ↗ |
| 2026-08-20 | @Reformed_Trader | +0.40 | Watches RXRX for a volume-backed breakout above its 200-day average and $4 resistance. | +0.0% | tweet ↗ |
| 2026-08-20 | @jrouldz | +0.15 | Lists four stocks being watched for possible future entries, without committing to a trade. | +0.0% | tweet ↗ |
| 2026-08-19 | @InvestmentGuru_ | +0.10 | References three earlier-moving stocks but provides no new entry intent. | -4.6% | tweet ↗ |
| 2026-08-19 | @iTradeCharts | +0.55 | Says RXRX is preparing for a downtrend breakout, with future entry areas marked. | -4.6% | tweet ↗ |
| 2026-08-19 | @FloridaHokie20 | +0.70 | Calls RXRX a major potential winner. | -4.6% | tweet ↗ |
| 2026-08-19 | @beach_trades | +0.45 | Frames RXRX as an AI-biotech stock with heavy short interest. | -4.6% | tweet ↗ |
| 2026-08-19 | @Reformed_Trader | +0.70 | Says an AI-biotech rotation may be starting and discloses positions in four favored names. | -4.6% | tweet ↗ |
| 2026-08-18 | @CaesarCapitalz | +0.40 | Names ABCL as a favorite and describes PRME and RXRX as promising. | +8.1% | tweet ↗ |
| 2026-08-17 | @CaesarCapitalz | +0.45 | The author hopes RXRX and PRME follow ABCL's positive trajectory as biotech attention increases. | +7.4% | tweet ↗ |
| 2026-08-17 | @BullrunIO | +0.00 | States these named positions have been fully sold. | +7.4% | tweet ↗ |
| 2026-08-16 | @jrouldz | +0.35 | Identifies four stocks tied to a biotech/AI crossover thesis, including two existing holdings. | +5.7% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.